These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 34731149)

  • 1. EMX2OS plays a prognosis-associated enhancer RNA role in gastric cancer.
    Liu GX; Tan YZ; He GC; Zhang QL; Liu P
    Medicine (Baltimore); 2021 Oct; 100(41):e27535. PubMed ID: 34731149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of enhancer RNA EMX2OS is associated with poor prognosis in kidney renal clear cell carcinoma.
    Jiang H; Chen H; Wan P; Song S; Chen N
    Aging (Albany NY); 2020 Nov; 12(24):25865-25877. PubMed ID: 33234727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The downregulation of lncRNA EMX2OS might independently predict shorter recurrence-free survival of classical papillary thyroid cancer.
    Gu Y; Feng C; Liu T; Zhang B; Yang L
    PLoS One; 2018; 13(12):e0209338. PubMed ID: 30576338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive Analysis of Enhancer RNAs Identifies LINC00689 and ELFN1-AS1 as Novel Prognostic Biomarkers in Uveal Melanoma.
    Zhao S; Jiang H; Liu J; Li DY; Li B; Long QR; Zheng L; Gu H
    Dis Markers; 2022; 2022():5994800. PubMed ID: 35251374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DCP1A is an unfavorable prognostic-related enhancer RNA in hepatocellular carcinoma.
    Wu H; Zhang J; Bai Y; Zhang S; Zhang Z; Tong W; Han P; Fu B; Zhang Y; Shen Z
    Aging (Albany NY); 2021 Oct; 13(19):23020-23035. PubMed ID: 34609335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TBX5-AS1, an enhancer RNA, is a potential novel prognostic biomarker for lung adenocarcinoma.
    Cheng L; Han T; Chen B; Nie K; Peng W
    BMC Cancer; 2021 Jul; 21(1):794. PubMed ID: 34238250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive characterization of functional eRNAs in lung adenocarcinoma reveals novel regulators and a prognosis-related molecular subtype.
    Qin N; Ma Z; Wang C; Zhang E; Li Y; Huang M; Chen C; Zhang C; Fan J; Gu Y; Xu X; Yang L; Wei X; Yin R; Jiang Y; Dai J; Jin G; Xu L; Hu Z; Shen H; Ma H
    Theranostics; 2020; 10(24):11264-11277. PubMed ID: 33042282
    [No Abstract]   [Full Text] [Related]  

  • 8. eRNAs and Superenhancer lncRNAs Are Functional in Human Prostate Cancer.
    Zhang X; Pang P; Jiang M; Cao Q; Li H; Xu Y; Li Y; Chen X; Han J
    Dis Markers; 2020; 2020():8847986. PubMed ID: 33029258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of SLC44A3-AS1 Enhancer RNA in Esophageal Cancer Prognosis.
    Kang K; Wu J; Mao Y; Kai J; Chen S; Xiong F
    J Coll Physicians Surg Pak; 2023 Sep; 33(9):964-971. PubMed ID: 37691355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional roles of antisense enhancer RNA for promoting prostate cancer progression.
    Pan CW; Wen S; Chen L; Wei Y; Niu Y; Zhao Y
    Theranostics; 2021; 11(4):1780-1794. PubMed ID: 33408781
    [No Abstract]   [Full Text] [Related]  

  • 11. A four-enhancer RNA-based prognostic signature for thyroid cancer.
    Liang Y; Zhang Q; Xin T; Zhang DL
    Exp Cell Res; 2022 Mar; 412(2):113023. PubMed ID: 35033555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FOXP4-AS1 is a favorable prognostic-related enhancer RNA in ovarian cancer.
    Hua T; Tian YJ; Wang RM; Zhao CF; Kong YH; Tian RQ; Wang W; Ma LX
    Biosci Rep; 2021 Apr; 41(4):. PubMed ID: 33870423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulated expression of MNX1-AS1 long noncoding RNA predicts poor prognosis in gastric cancer.
    Zhang W; Huang L; Lu X; Wang K; Ning X; Liu Z
    Bosn J Basic Med Sci; 2019 May; 19(2):164-171. PubMed ID: 30821221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic signatures and potential pathogenesis of eRNAs-related genes in colon adenocarcinoma.
    Rong H; Li Y; Hu S; Gao L; Yi T; Xie Y; Cai P; Li J; Dai X; Ye M; Liao Q
    Mol Carcinog; 2022 Jan; 61(1):59-72. PubMed ID: 34622496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cis-acting lnc-eRNA SEELA directly binds histone H4 to promote histone recognition and leukemia progression.
    Fang K; Huang W; Sun YM; Chen TQ; Zeng ZC; Yang QQ; Pan Q; Han C; Sun LY; Luo XQ; Wang WT; Chen YQ
    Genome Biol; 2020 Nov; 21(1):269. PubMed ID: 33143730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated analysis of a ceRNA network reveals potential prognostic lncRNAs in gastric cancer.
    Qi M; Yu B; Yu H; Li F
    Cancer Med; 2020 Mar; 9(5):1798-1817. PubMed ID: 31923354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IGF2-AS affects the prognosis and metastasis of gastric adenocarcinoma via acting as a ceRNA of miR-503 to regulate SHOX2.
    Huang J; Chen YX; Zhang B
    Gastric Cancer; 2020 Jan; 23(1):23-38. PubMed ID: 31183590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Integrative Analysis Revealing ZFHX4-AS1 as a Novel Prognostic Biomarker Correlated with Immune Infiltrates in Ovarian Cancer.
    Huang C; Cui H; Lang X; Zhao F
    J Immunol Res; 2022; 2022():9912732. PubMed ID: 35795530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LINC00887 Acts as an Enhancer RNA to Promote Medullary Thyroid Carcinoma Progression by Binding with FOXQ1.
    Liu D; Wang W; Wu Y; Qiu Y; Zhang L
    Curr Cancer Drug Targets; 2024; 24(5):519-533. PubMed ID: 38804344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential mechanisms and prognostic model of eRNAs-regulated genes in stomach adenocarcinoma.
    Gao L; Rong H
    Sci Rep; 2022 Oct; 12(1):16545. PubMed ID: 36192427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.